未找到相关数据
Allogeneic donor-derived CD19 CAR-T therapy of relapsed B-cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation
被引：0
作者：
马润芝
机构：
[1] StateKeyLab,HematolExperiment,NatlClinBloodDisResCenter,InstitHemat&BloodDisHosp,CAMS&PUMC
关键词：
D O I：
暂无
中图分类号：
R733.71 [急性白血病];
学科分类号：
100214 ;
摘要：
<正>Objective To investigate the long term efficacy and side effects of a donor-derived CD19 chimeric antigen receptor (CAR) T-cell (HI19α-4-1BB-ζCAR-T) therapy in the treatment of patients with relapsed B-cell acute lymphoblastic leukemia (B-ALL) after allogeneic hematopoietic stem cell transplantation (allo-HSCT)
引用
收藏
页码：228 / 229
页数：2
相关论文